Merck & Co Inc
XETRA:6MK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck & Co Inc
XETRA:6MK
|
US |
|
BRB Banco de Brasilia SA
BOVESPA:BSLI3
|
BR |
|
N
|
Nano Co Ltd
KOSDAQ:187790
|
KR |
|
M
|
MLS Co Ltd
SZSE:002745
|
CN |
|
Plazza AG
SIX:PLAN
|
CH |
|
Microbix Biosystems Inc
TSX:MBX
|
CA |
|
L
|
Lionco Pharmaceutical Group Co Ltd
SSE:603669
|
CN |
|
SUI Group Holdings Ltd
NASDAQ:SUIG
|
US |
|
Z
|
Zungwon En Sys Inc
KOSDAQ:045510
|
KR |
|
SunCoke Energy Inc
NYSE:SXC
|
US |
|
C
|
Central Holding Group Co Ltd
HKEX:1735
|
HK |
|
Argus Shanghai Textile Chemicals Co Ltd
SSE:603790
|
CN |
Bankruptcy Probability
Merck & Co Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Merck & Co Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Merck & Co Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Merck & Co Inc has total debt of 46.8B USD. This includes both short-term (0 USD) and long-term (46.8B USD) debt.
You can find a full breakdown on its Balance Sheet.
